FDA Inspection 1211374 — Kentucky Blood Center Inc

Kentucky Blood Center Inc — FEI 1000220419

The FDA completed an inspection of Kentucky Blood Center Inc on Jul 24, 2023 in Pikeville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 24, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pikeville, KY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.